Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 3 4 [Full Text] NextPage
Displaying Investigations 1 to 100 of 387 found
From 34 References


Abate et al 2017, Proc Natl Acad Sci U S A
  Peripheral T-cell lymphoma, unspecified
VAV1/MYO1F
t(19;19)(p13;p13)
T-Lineage

Asmann et al 2012, Cancer Res
  Adenocarcinoma Breast
DNM2/PIN1
t(19;19)(p13;p13)

Atak et al 2013, PLoS Genet
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
OAZ1/RNF126
t(19;19)(p13;p13)
T-Lineage

Babiceanu et al 2016, Nucleic Acids Res
  Nonneoplastic hematologic disorder/lesion Lymph node
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Skin
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Thyroid
CIRBP/C19ORF24
t(19;19)(p13;p13)
  Nonneoplastic epithelial disorder/lesion Uterus, corpus
CIRBP/C19ORF24
t(19;19)(p13;p13)

Durinck et al 2015, Nat Genet
  Adenocarcinoma Kidney
MIDN/SBNO2
t(19;19)(p13;p13)

Edgren et al 2011, Genome Biol
  Adenocarcinoma Breast
BSG/NFIX
t(19;19)(p13;p13)

Gu et al 2016, Nat Commun
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA4/TYK2
t(19;19)(p13;p13)
B-Lineage

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Kidney
ABCA7/COL5A3
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
ADGRE5/EPS15L1
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
AKAP8/CALR3
t(19;19)(p13;p13)
  Malignant melanoma Skin
AKAP8L/WIZ
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
AP3D1/DOT1L
t(19;19)(p13;p13)
  Squamous cell carcinoma Lung
ARHGEF18/TECR
t(19;19)(p13;p13)
  Acute myeloid leukemia, NOS
AZU1/TYK2
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
B3GNT3/INSL3
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
BRD4/AKAP8L
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
BTBD2/MOB3A
t(19;19)(p13;p13)
  Adenocarcinoma Large intestine
BTBD2/DOT1L
t(19;19)(p13;p13)
  Astrocytoma, grade I-II Brain
C19orf24/PALM
t(19;19)(p13;p13)
  Germ cell tumor, NOS Testis
C19orf25/REEP6
t(19;19)(p13;p13)
  Adenocarcinoma Oesophagus
C3/ZNF556
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
CARM1/CASP14
t(19;19)(p13;p13)
  Embryonal nervous system tumor, special type Adrenal
CC2D1A/ZSWIM4
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
CC2D1A/C19orf57
t(19;19)(p13;p13)
  Astrocytoma, grade I-II Brain
CELF5/RDH8
t(19;19)(p13;p13)
  Malignant melanoma Skin
CHERP/HSH2D
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
CIRBP/CNN2
t(19;19)(p13;p13)
  Adenocarcinoma Liver
CNN2/WDR18
t(19;19)(p13;p13)
  Astrocytoma, grade I-II Brain
COLGALT1/COPE
t(19;19)(p13;p13)
  Squamous cell carcinoma Unknown site
COLGALT1/CYP4F11
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
COPE/TMED1
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
CRB3/SAFB
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
CRTC1/KCNN1
t(19;19)(p13;p13)
  Adenocarcinoma Liver
CYP4F12/PTGER1
t(19;19)(p13;p13)
  Benign epithelial tumor, special type Thyroid
DAZAP1/SBNO2
t(19;19)(p13;p13)
  Squamous cell carcinoma Lung
DCAF15/C19orf57
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
DDA1/MYO9B
t(19;19)(p13;p13)
  Adenocarcinoma Breast
DNASE2/TRMT1
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
DNM2/RFX2
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
DNM2/ATG4D
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
DNM2/DAND5
t(19;19)(p13;p13)
  Adenocarcinoma Liver
DNM2/ANGPTL4
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
DNM2/RFX1
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
DNM2/NFIX
t(19;19)(p13;p13)
  Malignant melanoma Skin
DNM2/C19orf66
t(19;19)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
DNM2/MRPL4
t(19;19)(p13;p13)
  Malignant melanoma Eye
DNMT1/FDX1L
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
DNMT1/ADGRE1
t(19;19)(p13;p13)
  Germ cell tumor, NOS Testis
DOCK6/TMEM205
t(19;19)(p13;p13)
  Adenocarcinoma Oesophagus
DOCK6/NFIX
t(19;19)(p13;p13)
  Adenocarcinoma Large intestine
DOT1L/BTBD2
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
DOT1L/LSM7
t(19;19)(p13;p13)
  Diffuse large B-cell lymphoma
EEF2/TYK2
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
EEF2/SMARCA4
t(19;19)(p13;p13)
  Adenocarcinoma Breast
ELL/INSR
t(19;19)(p13;p13)
  Benign epithelial tumor, special type Thyroid
ELL/FKBP8
t(19;19)(p13;p13)
  Adenocarcinoma Oesophagus
ELL/MKNK2
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
EPS15L1/AKAP8
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
EPS15L1/CPAMD8
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
EVI5L/PGPEP1
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
FARSA/LYL1
t(19;19)(p13;p13)
  Adenocarcinoma Lung
FSD1/SHD
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
FZR1/CELF5
t(19;19)(p13;p13)
  Malignant melanoma Skin
FZR1/MFSD12
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
GATAD2A/KXD1
t(19;19)(p13;p13)
  Diffuse large B-cell lymphoma
GATAD2A/GIPC1
t(19;19)(p13;p13)
  Squamous cell carcinoma Lung
GZMM/HNRNPM
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
HAUS8/QTRT1
t(19;19)(p13;p13)
  Squamous cell carcinoma Uterus, cervix
HMHA1/ABCA7
t(19;19)(p13;p13)
  Squamous cell carcinoma Uterus, cervix
HMHA1/GRIN3B
t(19;19)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
HNRNPM/MCOLN1
t(19;19)(p13;p13)
  Adenocarcinoma Breast
HOOK2/NFIX
t(19;19)(p13;p13)
  Squamous cell carcinoma Lung
ICAM1/HNRNPM
t(19;19)(p13;p13)
  Adenocarcinoma Pancreas
ICAM3/TYK2
t(19;19)(p13;p13)
  Adenocarcinoma Prostate
ILF3/ZNF177
t(19;19)(p13;p13)
  Squamous cell carcinoma Uterus, cervix
ILF3/AP1M2
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
ILF3/ATG4D
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
ILF3/PDE4A
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
INSR/S1PR2
t(19;19)(p13;p13)
  Astrocytoma, grade I-II Brain
KDM4B/SBNO2
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
KLHL26/PGPEP1
t(19;19)(p13;p13)
  Adenocarcinoma Breast
KLHL26/KXD1
t(19;19)(p13;p13)
  Adenocarcinoma Lung
LDLR/SMARCA4
t(19;19)(p13;p13)
  Adenocarcinoma Adrenal
LDLR/CCDC130
t(19;19)(p13;p13)
  Adenocarcinoma Uterus, corpus
LONP1/RANBP3
t(19;19)(p13;p13)
  Adenocarcinoma Oesophagus
LONP1/FUT6
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
LONP1/DUS3L
t(19;19)(p13;p13)
  Transitional cell carcinoma Bladder
MAN2B1/RTBDN
t(19;19)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
MAP1S/CRTC1
t(19;19)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
MAU2/MAP1S
t(19;19)(p13;p13)
  Astrocytoma, grade I-II Brain
MED16/PALM
t(19;19)(p13;p13)
  Adenocarcinoma Ovary
MED16/POLR2E
t(19;19)(p13;p13)
  Adenocarcinoma Oesophagus
MEX3D/TCF3
t(19;19)(p13;p13)
  Adenocarcinoma Stomach
MIDN/HMHA1
t(19;19)(p13;p13)
  Malignant melanoma Skin
MIER2/SHC2
t(19;19)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
MLLT1/CRLF1
t(19;19)(p13;p13)
  Squamous cell carcinoma Unknown site
MOB3A/STK11
t(19;19)(p13;p13)

NextPage